Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing

Detection of minimal residual disease predicts adverse outcome in patients with acute myeloid leukemia. Currently, minimal residual disease may be detected by RQ-PCR or flow cytometry, both of which have practical and diagnostic limitations. Here, we describe a next-generation sequencing assay for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Salipante, Stephen J., Fromm, Jonathan R., Shendure, Jay, Wood, Brent L., Wu, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201902/
https://www.ncbi.nlm.nih.gov/pubmed/24743218
http://dx.doi.org/10.1038/modpathol.2014.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201902/
https://www.ncbi.nlm.nih.gov/pubmed/24743218
http://dx.doi.org/10.1038/modpathol.2014.57

Ejemplares similares